O-0019 * CALGB/SWOG 80405: PHASE III TRIAL OF...

Annals of Oncology 2014 / 06 Vol. 25; Iss. suppl 2

O-0019 * CALGB/SWOG 80405: PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN (FOLFIRI) OR OXALIPLATIN/5-FU/LEUCOVORIN (MFOLFOX6) WITH BEVACIZUMAB (BV) OR CETUXIMAB (CET) FOR PATIENTS (PTS) WITH KRAS WILD-TYPE (WT) UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON

Venook, A., Niedzwiecki, D., Lenz, H. J., Innocenti, F., Mahoney, M. R., O'Neil, B., Shaw, J., Polite, B., Hochster, H., Atkins, J., Goldberg, R., Mayer, R., Schilsky, R., Bertagnolli, M., Blanke, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu193.19
Date:
June, 2014
File:
PDF, 35 KB
english, 2014
Conversion to is in progress
Conversion to is failed